Aberrant hepatic TRIB3 gene expression in insulin-resistant obese humans

H Oberkofler1, A Pfeifenberger, S Soyal

  • 1Department of Laboratory Medicine, Landeskliniken and Paracelsus Private Medical University Salzburg, Müllner Hauptstr. 48, Salzburg, Austria. h.oberkofler@salk.at

Diabetologia
|May 13, 2010
PubMed
Abstract

Insights

Elevated hepatic TRIB3 (tribbles homologue 3) mRNA levels are linked to insulin resistance in obese humans. This study identifies potential gene regulation pathways for TRIB3 in the liver, offering insights into metabolic disease.

Area of Science:

  • Molecular biology
  • Human physiology
  • Metabolic research

Background:

  • Tribbles homologue 3 (Drosophila) (TRIB3) inhibits insulin signaling by interfering with v-akt murine thymoma viral oncogene homologue 1 (AKT1) phosphorylation.
  • Animal studies indicate increased TRIB3 expression during fasting and in diabetes models, potentially exacerbating hyperglycemia via enhanced hepatic glucose production.
  • Human data on TRIB3's role in insulin resistance is limited, though a gain-of-function mutation linked to insulin resistance has been reported.

Purpose of the Study:

  • To investigate the association between hepatic TRIB3 mRNA expression and insulin resistance in obese humans.
  • To identify potential transcriptional pathways regulating TRIB3 gene expression in the liver.

Main Methods:

  • Quantification of hepatic TRIB3 mRNA and key glucose homeostasis gene expression in obese patients with varying insulin resistance.
  • Assessment of biochemical variables related to intermediary metabolism.
  • In vitro analysis of TRIB3 promoter activity in HepG2 cells using specific nuclear receptor ligands and coactivators.

Main Results:

  • Hepatic TRIB3 mRNA expression correlated significantly with surrogate markers of insulin resistance in the study population.
  • A subgroup with high HOMA of insulin resistance (HOMA-IR) exhibited significantly increased TRIB3 mRNA levels compared to a low HOMA-IR group.
  • TRIB3 transcript levels showed positive correlations with mRNA expression of key metabolic regulators including PEPCK, PPARGC1A, PPARGC1B, USF1, FOXO1, and SREBP-1c.
  • Peroxisome proliferator-activated receptor alpha/retinoid X receptor pathway activation and overexpression of PPARGC1A, SREBP-1c, and PPARGC1B enhanced TRIB3 promoter activity in HepG2 cells.

Conclusions:

  • Aberrant hepatic TRIB3 transcript levels are implicated in insulin resistance among obese humans.
  • Potential transcriptional pathways, including those involving PPARGC1A, PPARGC1B, and SREBP-1c, are identified as regulators of TRIB3 gene expression in the liver.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...